What Will Happen to Innoviva Inc (NASDAQ:INVA) Next? The Stock Has Decline in Shorts

The stock of Innoviva Inc (NASDAQ:INVA) registered a decrease of 1.9% in short interest. INVA’s total short interest was 14.78M shares in September as published by FINRA. Its down 1.9% from 15.07 million shares, reported previously. With 903,700 shares average volume, it will take short sellers 16 days to cover their INVA’s short positions. The short interest to Innoviva Inc’s float is 22.24%.

The stock decreased 0.99% or $0.11 during the last trading session, reaching $11.49. About 217,940 shares traded. Innoviva, Inc. (NASDAQ:INVA) has declined 15.98% since September 13, 2018 and is downtrending. It has underperformed by 15.98% the S&P500.

Innoviva, Inc. engages in the development and commercialization of bio-pharmaceuticals. The company has market cap of $1.16 billion. The Company’s portfolio of respiratory products include RELVAR/BREO ELLIPTA, and ANORO ELLIPTA (umeclidinium bromide/ vilanterol, UMEC/VI). It has a 3.36 P/E ratio. The company, under its the Long-Acting Beta2 Agonist (LABA) collaboration agreement and the strategic alliance agreement with Glaxo Group Limited (GSK), is entitled to receive royalties on the sales of RELVAR/BREO ELLIPTA; and a 15% of any future payments made by GSK under its agreements relating to the combination FF/UMEC/VI and the Bifunctional Muscarinic Antagonist-Beta2 Agonist program, as monotherapy and in combination with other therapeutically active components.

More notable recent Innoviva, Inc. (NASDAQ:INVA) news were published by: Seekingalpha.com which released: “Why Innoviva Has 50% Upside – Seeking Alpha” on January 07, 2019, also Nasdaq.com with their article: “5 Biotech Stocks to Gain From Trade Deal Rally on the Horizon – Nasdaq” published on May 22, 2019, Finance.Yahoo.com published: “Those Who Purchased Innoviva (NASDAQ:INVA) Shares Five Years Ago Have A 49% Loss To Show For It – Yahoo Finance” on April 24, 2019. More interesting news about Innoviva, Inc. (NASDAQ:INVA) were released by: Finance.Yahoo.com and their article: “How Does Innoviva, Inc. (NASDAQ:INVA) Affect Your Portfolio Volatility? – Yahoo Finance” published on June 11, 2019 as well as Fool.com‘s news article titled: “3 Top Biotech Stocks to Buy in April – The Motley Fool” with publication date: April 08, 2019.

Innoviva, Inc. (NASDAQ:INVA) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.